12-year-old girl has IQ higher than Einstein's

London, October 5: With an IQ of 162, a 12-year-old schoolgirl in UK has been rated brainier than even Albert Einstein and Stephen Hawking.

Olivia Manning, from Liverpool, has been accepted into Mensa, the largest and oldest high IQ society in the world after she got a score of 162 in an Intelligence test.

Her score is not only two points better than German genius Einstein and physicist Hawking, it puts her in the top 1% of intelligent people in the world, the Daily Mail said. Being honoured with entry into Mensa means she will join a network of brains from across the globe.

Olivia admits having a knack for quickly absorbing and remembering new information, however, confessed being "speechless" after she discovered her score.

She barely needs a script - she said she learned her lines for a Macbeth production within 24 hours.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments